MX345624B - Derivados 6-amido de 4,5a-epoximorfinanos para tratamiento de dolor. - Google Patents

Derivados 6-amido de 4,5a-epoximorfinanos para tratamiento de dolor.

Info

Publication number
MX345624B
MX345624B MX2013004280A MX2013004280A MX345624B MX 345624 B MX345624 B MX 345624B MX 2013004280 A MX2013004280 A MX 2013004280A MX 2013004280 A MX2013004280 A MX 2013004280A MX 345624 B MX345624 B MX 345624B
Authority
MX
Mexico
Prior art keywords
epoxymorphinans
pain
treatment
amido derivatives
optionally substituted
Prior art date
Application number
MX2013004280A
Other languages
English (en)
Other versions
MX2013004280A (es
Inventor
Pasternak Gavril
Majumdar Susruta
Original Assignee
Memorial Sloan-Kettering Cancer Center *
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Memorial Sloan-Kettering Cancer Center * filed Critical Memorial Sloan-Kettering Cancer Center *
Publication of MX2013004280A publication Critical patent/MX2013004280A/es
Publication of MX345624B publication Critical patent/MX345624B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C07D489/04—Salts; Organic complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486—Analgesics, e.g. opiates, aspirine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Biotechnology (AREA)
  • Optics & Photonics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Compuestos de la fórmula en la cual R4 se elige de fenilo substituido, naftileno opcionalmente substituido, antraceno opcionalmente substituido y heterociclo aromático opcionalmente substituido, son útiles como analgésicos.
MX2013004280A 2010-10-19 2011-10-19 Derivados 6-amido de 4,5a-epoximorfinanos para tratamiento de dolor. MX345624B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39448110P 2010-10-19 2010-10-19
PCT/US2011/056827 WO2012054566A2 (en) 2010-10-19 2011-10-19 6-amido derivatives of 4,5a-epoxymorphinans for treatment of pain

Publications (2)

Publication Number Publication Date
MX2013004280A MX2013004280A (es) 2013-10-17
MX345624B true MX345624B (es) 2017-02-08

Family

ID=45975852

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013004280A MX345624B (es) 2010-10-19 2011-10-19 Derivados 6-amido de 4,5a-epoximorfinanos para tratamiento de dolor.

Country Status (12)

Country Link
US (3) US20130289060A1 (es)
EP (1) EP2630150B1 (es)
JP (1) JP6013345B2 (es)
KR (1) KR101960107B1 (es)
CN (1) CN103261203B (es)
AU (1) AU2011317183B2 (es)
BR (1) BR112013009505B1 (es)
CA (1) CA2814795C (es)
ES (1) ES2632932T3 (es)
IL (1) IL225755B (es)
MX (1) MX345624B (es)
WO (1) WO2012054566A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6013345B2 (ja) 2010-10-19 2016-10-25 メモリアル スローン−ケタリング キャンサー センター 痛み治療用の４，５ａ−エポキシモルフィナンの６−アミド誘導体
WO2015082932A1 (en) * 2013-12-05 2015-06-11 The University Of Bath Novel opioid compounds and their uses
US11046692B2 (en) 2015-04-30 2021-06-29 Memorial Sloan-Kettering Cancer Center Mitragynine analogs and uses thereof
EP3997092A4 (en) * 2019-07-08 2023-09-06 University of Health Sciences & Pharmacy in St. Louis G-PROTEIN POLARIZED OPIOID RECEPTOR AGONISTS/ANALGESICS WITH REDUCED ARRESTIN RECRUITMENT
CN111116395B (zh) * 2019-12-27 2023-04-07 湖北工业大学 多碘代芳香酸类化合物及其在抗腺病毒7型中的应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU666702B2 (en) * 1992-01-23 1996-02-22 Toray Industries, Inc. Morphinan derivative and medicinal use
CA2143318A1 (en) * 1993-06-30 1995-01-12 Hiroshi Nagase Antitussive agents
DE69414085T2 (de) * 1993-07-19 1999-03-18 Toray Industries, Inc., Tokio/Tokyo Wirkstoff zum schutze von gehirnzellen
AU686203B2 (en) * 1993-07-23 1998-02-05 Toray Industries, Inc. Morphinan derivative and medicinal use
EP0829481A1 (en) * 1996-09-16 1998-03-18 Pfizer Inc. Morphinan hydroxamic acid compounds
CA2270955C (en) * 1997-09-02 2007-08-07 Toray Industries Inc. Pharmaceutical composition containing morphinan derivative for treating drug dependence
CA2383146C (en) * 1999-08-24 2010-11-16 Hiroshi Nagase Therapeutic agent for neuropathic pain and neuropathic pain animal model
CA2403252A1 (en) * 2000-03-15 2001-09-20 Wolfgang Sadee Neutral antagonists and use thereof in treating drug abuse
CA2442423C (en) * 2001-03-30 2009-11-03 Toray Industries, Inc. Therapeutic drug for psychoneurotic disorders
ES2623362T3 (es) * 2004-05-28 2017-07-11 Human Biomolecular Research Institute Analgésicos metabólicamente estables y medicaciones para el dolor
EP1762569A1 (en) * 2005-09-12 2007-03-14 Alcasynn Pharmaceuticals Gmbh Novel 6-amino-morphinan derivatives, method of manufacturing them and their application as analgesics
WO2007039058A2 (en) * 2005-09-23 2007-04-12 Dsm Ip Assets B.V. Use of opioid receptor antagonists
JP5176188B2 (ja) * 2006-04-21 2013-04-03 ディーエスエム アイピー アセッツ ビー．ブイ． オピオイド受容体拮抗薬の使用
KR101477043B1 (ko) * 2007-04-24 2014-12-29 도레이 카부시키가이샤 디스키네시아의 치료 또는 예방제
EP2151241B1 (en) * 2007-04-26 2012-03-21 Toray Industries, Inc. Stable solid preparation comprising 4,5-epoxymorphinan derivative
WO2009044883A1 (ja) * 2007-10-05 2009-04-09 Toray Industries, Inc. モルヒナン誘導体またはその薬理学的に許容される酸付加塩を有効成分とする皮膚性状改善治療薬
US8778958B2 (en) * 2008-07-10 2014-07-15 John R. Cashman Synthesis of metabolically stable agents for alcohol and drug abuse
EP2356989B1 (en) * 2008-10-24 2018-02-07 Toray Industries, Inc. Stable tablet containing 4,5-epoxymorphinan derivative
EP2387577A4 (en) * 2009-01-16 2012-10-17 Univ Virginia Commonwealth STRONG AND SELECTIVE NON-PEPTIDYL MU OPIOID RECEPTOR ANTAGONISTS
WO2011020030A2 (en) * 2009-08-13 2011-02-17 The General Hospital Corporation Methods and compositions to prevent addiction
CA2787323C (en) * 2010-01-29 2017-08-29 Toray Industries, Inc. Therapeutic or prophylactic agent for biliary tract diseases
JP6013345B2 (ja) 2010-10-19 2016-10-25 メモリアル スローン−ケタリング キャンサー センター 痛み治療用の４，５ａ−エポキシモルフィナンの６−アミド誘導体
CN103327977B (zh) * 2011-01-31 2016-05-04 东丽株式会社 恶液质的治疗或预防剂

Also Published As

Publication number Publication date
JP6013345B2 (ja) 2016-10-25
MX2013004280A (es) 2013-10-17
US20140255308A1 (en) 2014-09-11
US10150775B2 (en) 2018-12-11
ES2632932T3 (es) 2017-09-18
WO2012054566A3 (en) 2012-07-19
CN103261203B (zh) 2017-06-20
CN103261203A (zh) 2013-08-21
WO2012054566A2 (en) 2012-04-26
CA2814795A1 (en) 2012-04-26
EP2630150A4 (en) 2014-04-30
IL225755B (en) 2018-10-31
CA2814795C (en) 2018-02-27
IL225755A0 (en) 2013-06-27
AU2011317183B2 (en) 2016-10-20
US20180057504A1 (en) 2018-03-01
US20130289060A1 (en) 2013-10-31
AU2011317183A1 (en) 2013-05-09
KR20130121110A (ko) 2013-11-05
KR101960107B1 (ko) 2019-03-19
US9725457B2 (en) 2017-08-08
EP2630150A2 (en) 2013-08-28
EP2630150B1 (en) 2017-04-12
BR112013009505B1 (pt) 2022-06-21
BR112013009505A2 (pt) 2016-07-26
JP2013541559A (ja) 2013-11-14

Similar Documents

Publication Publication Date Title
HRP20180662T1 (hr) 1,2,5-oksadiazoli kao inhibitori indolamin 2,3-dioksigenaze
JO3131B1 (ar) مركبات كيميائية
TN2011000279A1 (en) Novel pyrazole -4-n-alkoxycarboxamides as microbiocides
EA201201648A1 (ru) Стимуляторы sgc
MX2013004491A (es) Boronatos como inhibidores de arginasa.
MA33939B1 (fr) 5-alcynyl-pyrimidines
MX2013002851A (es) Inhibidores de tonum pectinacetilesterasa y metodos de su uso.
MY167898A (en) Co-crystals and salts of ccr3-inhibitors
MX345624B (es) Derivados 6-amido de 4,5a-epoximorfinanos para tratamiento de dolor.
TN2011000355A1 (en) Novel microbiocides
EA201300092A1 (ru) Замещенные производные оксадиазола
MX2012007837A (es) Derivados de oxazolopirimidina 2, 5 - sustituidos.
IN2012DN01223A (es)
IN2012DN02698A (es)
CR20130005A (es) Agentes terapéuticos 976
MX2013006670A (es) Derivado de 2-carboxamida-4-piperazinil-benzofurano.
EA201300408A1 (ru) Производные фенилхиназолина
UA101427C2 (en) Novel microbiocides
TN2010000583A1 (en) Organic compounds

Legal Events

Date Code Title Description
FG Grant or registration